A genetic test result can look unusually definite: a gene name, a technical code, a colored heading, and a word such as positive or negative. Yet the meaning comes from the complete report and the reason the test was performed. The same everyday word can carry different implications in a carrier test, a risk assessment, and a diagnostic evaluation.
A useful reading method separates three questions: What did the laboratory observe? What does the evidence suggest about that observation? What does it mean in the person's actual context? Our overview of DNA and genome testing explains the range of tests that may sit behind a report.
Start with the identity and scope of the document
Before interpreting a highlighted result, locate the test name, laboratory, report date, specimen information, and reason for testing. Check that you have the full report rather than a portal summary, an email excerpt, or a screenshot of one result. These condensed formats can omit qualifications that matter.
Next, find the methods and limitations sections. Which genes, regions, or particular variants were examined? What kinds of changes were included? Does the document describe a clinical laboratory analysis, a consumer report, or a research finding? If a field is missing or unclear, turn it into a question instead of filling the gap yourself.
Keep a copy of the original document. When asking for help, the exact wording is more useful than a recollection such as “something was abnormal.” The aim of this first pass is simply to identify what the report claims to cover.
Make a small question log as you read. Record the exact term, where it appears, and what you think it means. For example, “Does this phrase describe the laboratory finding or my chance of developing a condition?” is more answerable than “Is this good or bad?” You do not need to decode every abbreviation before seeking an explanation.
Understand what “positive” refers to
A positive result means that the test identified a finding relevant to its purpose. Depending on the test, that could support a diagnosis, indicate carrier status, identify increased susceptibility, or lead to further investigation. It does not have a single universal meaning.
Ask the person explaining the report to complete this sentence: “Positive for this test means that….” Then ask what it does not establish. A result associated with increased susceptibility does not necessarily show that a condition is present, when it might develop, or how it would affect the person.
Screening and diagnostic testing also serve different purposes. A screening result can identify a reason for further evaluation; it should not be silently translated into a confirmed diagnosis. The report's intended use is part of its meaning, not an administrative footnote.
Read variant classifications carefully
Clinical reports may use categories such as pathogenic, likely pathogenic, uncertain significance, likely benign, and benign. These categories describe the evidence for a variant's relationship to disease in a relevant context. They do not rank how unwell a person is.
A variant of uncertain significance, often shortened to VUS, means that the evidence is insufficient or conflicting about the variant's health significance. It is not a diagnosis or a prediction that the variant will eventually prove harmful. The uncertainty concerns interpretation; it does not necessarily mean the laboratory failed to detect the DNA change accurately.
A VUS alone is not a sound basis for medical decisions. Ask what additional evidence could clarify it and whether the laboratory has a process for reconsidering the classification. Avoid converting “uncertain” into either “dangerous” or “irrelevant.” Both translations claim more than the evidence provides.
Also distinguish a variant from a gene. Many different variants can occur in the same gene, with different meanings. An online story about that gene may concern an entirely different change.
A negative result needs a complete sentence
Try reading negative as “the test did not identify the relevant finding within its scope.” That phrasing leaves room for the limitations that a standalone reassuring label can conceal.
In inherited cancer testing, a negative result can be particularly informative when the laboratory specifically assessed a known harmful familial variant. It may show that the tested person did not inherit that variant. A negative result can be less informative when the family's possible genetic explanation is still unknown. The National Cancer Institute's genetic testing fact sheet explains this distinction between a true negative and an uninformative negative.
Even an informative negative is not a guarantee of freedom from disease. Ask which possibility the result makes less likely and which concerns remain outside the test. Personal and family history can still matter after a negative report. This is why the interpretation cannot be separated from the original question.
Put risk numbers on a common scale
A report may describe relative risk, absolute risk, or a comparison with a reference population. Those are different presentations. Ask what group is being used for comparison, what time period applies, and whether the estimate includes factors beyond the genetic finding.
Consider a purely hypothetical example: a risk increasing from 2 in 100 to 4 in 100 has doubled, but the absolute difference is 2 percentage points. Both descriptions are mathematically correct. Neither figure describes your risk; the example shows why “twice as likely” is incomplete without the starting value and timeframe.
For some genetic conditions, people with the same relevant variant do not all develop symptoms. This is called reduced penetrance. Features can also differ among affected people, a concept called variable expressivity. These ideas explain why identifying a variant may leave questions about outcome, timing, or severity unresolved.
Do not treat every file as an interpreted clinical report
A raw genotype download, a third-party analysis, and a clinical laboratory report are different products. Consumer raw data can be difficult to interpret, and uploading it to another service creates another set of privacy and interpretation questions. More annotations do not automatically mean stronger evidence.
If a consumer or third-party result appears medically significant, ask a healthcare professional what kind of review or confirmation is appropriate. Preserve the original source and report so the finding can be traced. Searching the same code across many websites can amplify confusion when those sites use different assumptions or evidence.
Our guide to DNA testing privacy covers the questions to consider before sharing a downloadable file. For the technical distinction between selected markers and sequence data, see genotyping versus sequencing.
Ask why two reports appear to disagree
Begin by checking whether they evaluated the same thing. Compare the named variant, test scope, report dates, and stated interpretation. A report that does not mention a finding has not necessarily tested for and excluded it.
Different laboratories or services may examine different variants or interpret evidence differently. A later report may also draw on information that was unavailable earlier. Instead of trying to decide which report “wins,” ask the relevant professional to explain the source of the difference.
A useful question is: “Is the disagreement about whether the variant is present, what it means, or whether it was included in the analysis?” Those possibilities call for different explanations. Keeping them separate makes the conversation more precise.
Plan the next conversation, including family questions
Results can have implications for biological relatives, but your report is not their test result. A genetic counselor can help explain what information might be useful to share and how relatives can consider their own questions. Sharing the exact report, where appropriate and with attention to privacy, is more informative than passing along a disease label.
Our genetic counseling guide explains how to prepare. Bring the complete document and a short list of uncertainties. Ask who handles future questions, whether reclassification notifications are offered, and how to keep contact information current.
Before the conversation ends, try summarizing the result in your own words: what was found, what that supports, what remains unresolved, and who is responsible for any follow-up. A careful interpretation should make those boundaries clearer. The goal is an accurate understanding of the report, including its limits, rather than extracting certainty from every technical detail.
